McMillan Shakespeare Limited
ASX: MMS
Margins Squeezed Amid Strategic Spend Despite Stable Revenue Growth
(Source: TradingView) 3-Month Performance Profile of MMS compared to the S&P/ASX 200 (XJO).
McMillan Shakespeare’s 1H FY25 fundamentals present a mixed picture. While statutory NPAT rose modestly, normalised UNPATA dropped 6.7%, indicating underlying margin pressure. The company saw a sli
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
